INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Accelerating Clinical Supply Through Integrated Drug Development
See how parallel processing integrates clinical supply into drug development, enabling simultaneous workstreams that address packaging, labeling, and sourcing challenges before manufacturing completes.
-
The Rise Of Targeted Modalities In Pharmaceutical Development
Targeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.
-
Navigating Late-Phase Clinical Trial Enrollment: Strategies To Stay On Schedule
Late-phase trial delays cause massive revenue loss. This piece outlines AI pre-screening, direct-to-patient scaling, and retention tactics to hit study goals on time and ensure market readiness.
-
Securing Sponsor Reimbursement For CRIO Fees
Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.
-
Transparent Pricing In Bioanalysis: A Feature, Not A Bonus3/9/2026
Unclear CRO pricing leaves small biotechs vulnerable to budget swings. Transparent, itemized costs cut financial risk, sharpen planning, and build trust by setting expectations from the start.
-
Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments1/15/2025
Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties
-
5 Outdated Practices Holding Back Modern Bioanalysis10/20/2025
Bioanalysis must replace outdated paper, manual processes, and disjointed systems with integrated, automated platforms for continuous validation, efficiency, compliance, and to support complex modern therapies.
-
Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your Trial3/9/2026
Evaluate the risks of staying with an underperforming RTSM provider versus the benefits of a mid-study transition. Modern migration tools now offer a secure path to protect trial data and timelines.
-
Why Are Clinical Research Meetings Harder To Plan Right Now?6/19/2026
Are your clinical meetings setting your study up for success, or creating avoidable challenges? Watch the presentation to learn how to build alignment from the start.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
With this single, purpose-built platform, uncover how sponsors can deliver greater quality, oversight, and efficiency throughout the entire imaging lifecycle.
-
Niche CRO with a difference
Worldwide Clinical Trials Oncology is a niche oncology CRO devoting time, energy, and capital to supporting biotechs in bringing next-generation therapies to patients in need. Oncology clinical research is complex, demanding, and continually evolving. Bringing effective therapies to proof-of-concept and then to market as fast as possible is our passion because every second counts for patients with cancer and their families.
-
Recognized globally as a CNS Center of Excellence, Altasciences has completed more than 200 preclinical and clinical neurological studies, in addition to providing formulation, manufacturing, and analytical testing services, as well as bioanalytical support. Speak with one of their experts!
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Built From The Ground Up
Block Clinical understood from the beginning that intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.